Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND

被引:14
作者
Kuwajerwala, Nafisa Kayam [1 ,2 ]
Feczko, Claire
Dekhne, Nayana [1 ,2 ]
Pettinga, Jane [1 ,2 ]
Lucia, Victoria C. [3 ]
Riutta, Justin
Vicini, Frank [4 ]
机构
[1] William Beaumont Hosp, Dept Surg, Troy, NY USA
[2] William Beaumont Hosp, Dept Surg, Royal Oak, MI 48072 USA
[3] William Beaumont Hosp, Res Inst, Royal Oak, MI USA
[4] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48072 USA
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2013年 / 36卷 / 01期
关键词
lymphedema; immediate ALND; delayed ALND; SLNB; BREAST-CANCER; COOPERATIVE GROUP; TRIAL; MORBIDITY;
D O I
10.1097/COC.0b013e31823a4956
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the study was to show that delayed axillary lymph node dissection (ALND) has higher rates of lymphedema compared with immediate ALND, using data from NSABP-B32 at Beaumont Hospital. Method: NSABP B-32 at Beaumont had 207 patients with follow-up data on 199 patients, randomizing clinically negative axilla to sentinel lymph node biopsy (SLNB)+ALND (GrA N = 98), and SLNB+cytology +/- ALND (GrB N = 101). All patients had preoperative volumetric arm measurements and only node negatives had routine postoperative measurements assessing lymphedema for 36 months. We contacted node-positive patients for postoperative measurements for this study. Twenty-four and 15 cytology-positive patients had SLNB+ALND in GrA and GrB, respectively (SubGrA1 N = 24; SubGrB1 N = 15). Fourteen hematoxylin and eosin-positive patients had delayed ALND (SubGrB2a N = 14). Results: Lymphedema rate for node-positive SLNB+ALND was 10.3% [SubGrA1 (3/24)+SubGrB1 (1/15) = 4/39] and node-negative SLNB+ALND was 6.8% (SubGrA2 = 5/74). Lymphedema was 14.3% for delayed ALND in SubGrB2a (2 of 14) and 0% for 72 SLNBs in SubGrB2b. Our study comparing immediate and delayed ALND lymphedema was not statistically significant (10.3% vs. 14.3%, P = 0.65). Comparing node-negative ALND (SubGrA2 = 5/74 = 6.8%) to node-positive ALND (A1+B1+B2a = 6/53 = 11.3%) was not statistically significant (P = 0.52). Comparing lymphedema for node-negative ALND (SubGrA2) to SLNB (SubGrB2b) only approached significance (6.8% vs. 0%, P = 0.058). Conclusions: The rate of lymphedema was higher in delayed ALND but not statistically significant. Comparison, however, is difficult, given the limited sample size. We urge the other centers of NSABP-B32 to validate this, by contacting the node-positive patients for measurements. The lymphedema rate for SLNB alone was 0% and approached statistical significance when compared with node-negative ALND.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 11 条
[1]   Sentinel lymphadenectomy in breast cancer [J].
Giuliano, AE ;
Jones, RC ;
Brennan, M ;
Statman, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2345-2350
[2]   The sentinel node in breast cancer - A multicenter validation study [J].
Krag, D ;
Weaver, D ;
Ashikaga, T ;
Moffat, F ;
Klimberg, VS ;
Shriver, C ;
Feldman, S ;
Kusminsky, R ;
Gadd, M ;
Kuhn, J ;
Harlow, S ;
Beitsch, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :941-946
[3]  
Krag D., 1998, BREAST, V2, P67
[4]   NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial [J].
Krag, DN ;
Julian, TB ;
Harlow, SP ;
Weaver, DL ;
Ashikaga, T ;
Bryant, J ;
Single, RM ;
Wolmark, N .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (03) :208S-210S
[5]   Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: A study from the Danish Breast Cancer Cooperative Group [J].
Madsen, Anders Husted ;
Haugaard, Karen ;
Soerensen, Jan ;
Bokmand, Susanne ;
Friis, Esbern ;
Holtveg, Helle ;
Garne, Jens Peter ;
Horby, John ;
Christiansen, Peer .
BREAST, 2008, 17 (02) :138-147
[6]  
MAUNSELL E, 1993, CAN J SURG, V36, P315
[7]   Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial [J].
Purushotham, AD ;
Upponi, S ;
Klevesath, MB ;
Bobrow, L ;
Millar, K ;
Myles, JP ;
Duffy, SW .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4312-4321
[8]   Lymphedema following axillary lymph node dissection for breast cancer [J].
Sakorafas, George H. ;
Peros, George ;
Cataliotti, Luigi ;
Vlastos, George .
SURGICAL ONCOLOGY-OXFORD, 2006, 15 (03) :153-165
[9]   The Risk of Developing Arm Lymphedema Among Breast Cancer Survivors: A Meta-Analysis of Treatment Factors [J].
Tsai, Rebecca J. ;
Dennis, Leslie K. ;
Lynch, Charles F. ;
Snetselaar, Linda G. ;
Zamba, Gideon K. D. ;
Scott-Conner, Carol .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1959-1972
[10]   Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes [J].
Veronesi, U ;
Paganelli, G ;
Galimberti, V ;
Viale, G ;
Zurrida, S ;
Bedoni, M ;
Costa, A ;
deCicco, C ;
Geraghty, JG ;
Luini, A ;
Sacchini, V ;
Veronesi, P .
LANCET, 1997, 349 (9069) :1864-1867